Syngene’s Regulatory Report Card: USFDA Says ‘Good Job, Just Polish a Bit!

Syngene International Ltd, the leading integrated research, development, and manufacturing services group, has been issued the Establishment Inspection Report (EIR) by the US Food and Drug Administration (USFDA) for Bengaluru. The inspection result has been classified as "Voluntary Action Indicated" (VAI), and it reflects the company's sustained direction towards regulatory compliance and quality.

 

Key Highlights:

 

"The company will be in close liaison with USFDA and is committed to addressing these observations in a comprehensive manner within the stipulated time," Syngene International said in a statement.

 

Source: Business Standard, Medical Dialogues, StockInsights.ai, JM Financial Services, LinkedIn